TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
FRMI

Fermi Inc.

Real Estate · REIT - Specialty · listed since 2025

5.00$ +3.8% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

Why this colour

Red here is not about a valuation question — it reflects a substance finding Fermi has documented itself: the quarterly report as of March 31, 2026 states, in its own words, "substantial doubt" about its ability to continue as a going concern, because available resources do not cover planned spending over the next twelve months — an assessment the company, in the same report, says its own countermeasures alleviate, though explicitly without a guarantee of success and still listed as its own risk factor. On top of that sits a documented leadership crisis: the founder and CEO left the company in April 2026, then waged an open proxy fight for control of the board, a director resigned amid the dispute, and a securities class action alleges the company misled investors at the IPO about exactly the tenant risk that materialized a month later. The July 14, 2026 convertible notes bring real, additional capital on top of the measures already factored into the May filing. Whether the combination is actually enough will only be confirmed by the next report. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Fermi Inc. has poured more than a billion dollars into a real construction project within a year and a half — but still reports zero revenue, has no signed lease, and its own quarterly report states "substantial doubt" about its ability to continue as a going concern — doubt that Fermi, in the same report, says its own plans alleviate, though explicitly without a guarantee of success. On top of that come the founder's departure as CEO, a months-long proxy fight for control of the board, and a pending securities class action. The July 2026 convertible notes provide additional capital on top of management's own plan. Not investment advice.

Going Concern & Liquidity

In its quarterly report as of March 31, 2026, Fermi itself states "substantial doubt" about its ability to continue as a going concern: cash plus restricted cash totaling $243.3 million is not enough to cover planned spending over the next twelve months. The net financial position flipped from +$298.7 million to −$213.8 million within a single quarter (excluding $35.8 million of restricted cash; including it, −$178.0 million). Fermi itself states, in the same report, that its own plans (credit lines, equipment monetization) alleviate this doubt — without a guarantee of execution, and still listed as its own risk factor.

Project Scale vs. Capital Base

Total capital needs across all of Project Matador's construction phases are estimated by the company itself at $70 billion to $90 billion — 15 to 19 times today's market capitalization of roughly $4.7 billion (07/26/2026). As of March 31, 2026, there is still no signed lease; the first prospective tenant terminated its $150 million funding commitment in December 2025.

Leadership & Control

Founder and CEO Toby Neugebauer left the company on April 17, 2026, and then waged a — suspended in July 2026 — proxy fight for control of the board; a director he had designated resigned amid the dispute on July 10, 2026. Since July 20/22, 2026, an entirely new executive team has run the company, but still without a permanent CEO.

Legal Risk

A securities class action, Lupia v. Fermi Inc. (Case No. 1:26-cv-00050, U.S. District Court for the Southern District of New York), has been pending since January 5, 2026, alleging misleading statements about tenant demand at the IPO — an allegation by the plaintiffs, which Fermi denies and says it intends to defend vigorously.

Fresh Capital & Substance

On July 14, 2026, Fermi raised $431.25 million through convertible notes (net proceeds of $416.8 million), in addition to $745.6 million of net IPO proceeds; against that stand $1,430.9 million of real property, plant, and equipment (turbines, substations) and a 99-year ground lease with the Texas Tech University System. This capital comes on top of the measures Fermi had already cited, in the same quarterly report, as alleviating the going-concern doubt.

Valuation

A price-to-earnings ratio doesn't exist without revenue; on a book-value basis, the stock costs roughly 4.4 times equity per share (data as of 07/26/2026), at a price just under two-thirds below the $21.00 IPO price (10/02/2025). The capped-call hedges on the convertible notes treat a doubling to the $14.64 cap price as a possibility, not an expectation — without attaching a timeframe.

Worth Noting

The hook for this analysis is issue 24 of the "Hot Stocks Europe" newsletter dated November 28, 2025 (reader submission); every company figure comes from the SEC filings and fundamental data, not from the newsletter. The newsletter itself discloses a conflict of interest: the publisher, author, or related third parties may hold positions in the securities discussed and intend to sell into rising prices (EU Market Abuse Regulation No. 596/2014).

Data as of: SEC filings through the Form 10-Q as of March 31, 2026 (filed May 15, 2026), plus required disclosures (Form 8-K) through July 23, 2026; market data (market capitalization, price-to-book) as of July 26, 2026.

Not to be confused: Fermi Inc. trades on the Nasdaq and the London Stock Exchange, each in U.S. dollars (not pence); its German secondary listings (tickers H3V and A41MPN) trade in euros and are outside the scope of this analysis.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at FRMI since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 4.60 $ to 32.50 $ · Last price: 5.00 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 3.2$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 641m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 72.2%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market.

Performance

Perf. 1M ?Price performance over the last month.
Perf. 3M ?Price performance over the last 3 months.
Perf. 6M ?Price performance over the last 6 months.
YTD Performance (%) ?Price performance since the start of the year (Year to Date).
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high.
Perf. Since Inception ?Price performance since the first available trading day (10/01/2025) — with a complete history, that is since the IPO. -84.78%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 5.80$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 6.00$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 7.60$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 42.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 104.7%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity. 3.5
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable.
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 0.0
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power.
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 0.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity?
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). 0.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag.

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY).
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY).
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before.
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee.
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line.
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks.
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth.
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. E (21 out of 100)

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: REIT - Specialty

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Fermi Inc. FRMI 3.2 0.0
Equinix Inc EQIX 101.2 71.1 27.7 52.0 24.3 5.9 34.6
American Tower Corp AMT 81.8 29.8 17.0 73.8 45.9 5.1 -7.5
Digital Realty Trust Inc DLR 66.1 49.5 26.9 57.0 17.2 10.0 10.7
Iron Mountain Incorporated IRM 33.9 122.6 21.0 54.2 21.0 12.2 15.5
Crown Castle CCI 32.2 32.5 20.1 73.7 47.7 -35.1 -17.7
SBA Communications Corp SBAC 19.0 19.3 17.0 74.2 52.4 5.1 -6.8
Weyerhaeuser Company WY 15.5 38.7 18.0 14.5 9.0 -3.1 -8.3
Lamar Advertising Company LAMR 14.9 27.3 18.7 67.4 25.3 2.7 21.8
Median of companies shown 32.2 35.6 18.7 62.2 24.8 5.1 2.0

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2025 · Revenue: 0 $M 2025 · Operating income: -178 $M 2025 · Net income: -486 $M
2025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2025 0 -178 -486 -1.04 -34 1,096 1,413

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2025: Q1 · 0.0 $M Q1 2025: Q2 · 0.0 $M Q2 2025: Q3 · 0.0 $M Q3 2025: Q4 · 0.0 $M Q4 2026: Q1 · 0.0 $M Q1

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2025: Q1 0.00 0 0 0
2025: Q2 -0.02 0 -3 -45
2025: Q3 -0.84 0 -6 -59
2025: Q4 -0.21 0 -26 -499
2026: Q1 -0.30 0 -7 -449
2026: Q2 -0.04 -100.00 -49 -234

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 3 of our scanner strategies — each hit links to the scanner.

Backtested Scanners

Breakout & Setup

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus
Analyst Ratings
Price Target (average) 17.13$
Distance to price 242.6% The price target sits 242.6% above the current price.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -0.36 -0.60 – -0.07 43 68.2% 4
12/31/2027 0.12 -0.24 – 0.45 867 132.3% 5

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.

How the Rating Is Built

Quality check

AAQS

1/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5%
  • Exp. sales growth 3Y > 5%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5%
  • Net debt < 4x EBIT
  • EBIT positive, 10Y straight
  • Max. EBIT decline < 50%
  • Return on equity > 15% -44.4%
  • ROCE > 15% -14.4%
  • Expected return > 10%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Aug 20, 2026 Ortiz Blanes Jacobo Chief Operating Officer Other 147,059 0.00
Aug 14, 2026 Mcintire Lee A Chief Executive Officer Other 468,750 0.00

View all insider transactions →

The company

About the Company

Employees
35
Headquarters
Amarillo, TX
Address
620 South Taylor Street, 79101 Amarillo, United States
Phone
214 894 7855
IPO Date
10/01/2025
ISIN
US3149111086

Management

Management
Name Title Birth Year
Jacobo Ortiz Blanes Chief Operating Officer 1972
Charles Lynn Hamilton Chief Site Officer 1974
Lee Alan McIntire CEO & Director 1949
Robert L. Masson II Chief Financial Officer 1971
Barry Sievert Vice President of Investor Relations
Sezin Uzman VP of Nuclear Supply Chain & Compliance
George Wentz General Counsel
Lawrence M. Kellerman Chief Power Officer & Director 1966
Mesut Uzman Chief Nuclear Officer 1974
John W Donovan Jr. Executive Vice President of Capital Markets

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/31/2026 Fermi Inc. (FRMI): Shareholder Nominations Pursuant to Exchange Act Rule 14a-11; Other Events SEC ↗
  • 08/13/2026 Fermi Inc. (FRMI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 08/13/2026 Fermi Inc. (FRMI): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/23/2026 Fermi Inc. (FRMI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 07/15/2026 Fermi Inc. (FRMI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
  • 07/13/2026 Fermi Inc. (FRMI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 07/09/2026 Fermi Inc. (FRMI): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?